Department of Surgery, Maastricht University Medical Centre, Amsterdam, The Netherlands.
Crit Care Med. 2012 Mar;40(3):766-9. doi: 10.1097/CCM.0b013e318232e2e7.
Organ donation after cardiac death increases the number of donor organs. In controlled donation after cardiac death donors, the period between withdrawal of life-sustaining treatment and cardiac arrest is one of the parameters used to assess whether organs are suitable for transplantation. The objective of this study was to identify donation after cardiac death donor characteristics that affect the interval between withdrawal of life-sustaining treatment and cardiac death.
Prospective multicenter study of observational data.
All potential donation after cardiac death donors in The Netherlands between May 2007 and June 2009 were identified.
None.
Of the 242 potential donation after cardiac death donors, 211 entered analysis, 76% of them died within 60 mins, and 83% died within 120 mins after withdrawal of life-sustaining treatment. The median time to death was 20 mins (range 1 min to 3.8 days). Controlled mechanical ventilation, use of norepinephrine, absence of reflexes, neurologic deficit as cause of death, and absence of cardiovascular comorbidity were associated with death within 60 and 120 mins. The use of analgesics, sedatives, or extubation did not significantly influence the moment of death. In the multivariable logistic regression analysis, controlled mechanical ventilation remained a risk factor for death within 60 mins, and norepinephrine administration and absence of cardiovascular comorbidity remained risk factors for death within 120 mins. The clinical judgment of the intensivist predicted death within 60 and 120 mins with a sensitivity of 73% and 89%, respectively, and a specificity of 56% and 25%, respectively.
Despite the identification of risk factors for early death and the additional value of the clinical judgment by the intensivist, it is not possible to reliably identify potential donation after cardiac death donors who will die within 1 or 2 hrs after life-sustaining treatment has been withdrawn. Consequently, a donation procedure should be initiated in every potential donor.
心脏死亡后的器官捐献增加了供体器官的数量。在控制性心脏死亡后供体中,从停止生命支持治疗到心脏骤停的时间是评估器官是否适合移植的参数之一。本研究的目的是确定影响停止生命支持治疗与心脏死亡之间间隔的心脏死亡后供体特征。
前瞻性多中心观察数据研究。
2007 年 5 月至 2009 年 6 月期间荷兰所有潜在的心脏死亡后供体均被确定。
无。
在 242 名潜在的心脏死亡后供体中,211 名进入分析,其中 76%在 60 分钟内死亡,83%在停止生命支持治疗后 120 分钟内死亡。中位死亡时间为 20 分钟(范围 1 分钟至 3.8 天)。控制性机械通气、使用去甲肾上腺素、无反射、作为死亡原因的神经功能缺损以及无心血管合并症与 60 分钟和 120 分钟内死亡相关。使用镇痛药、镇静剂或拔管并未显著影响死亡时间。在多变量逻辑回归分析中,控制性机械通气仍然是 60 分钟内死亡的危险因素,去甲肾上腺素的使用和无心血管合并症仍然是 120 分钟内死亡的危险因素。重症监护医师的临床判断对 60 分钟和 120 分钟内的死亡具有 73%和 89%的敏感性,特异性分别为 56%和 25%。
尽管确定了早期死亡的危险因素以及重症监护医师的临床判断具有额外价值,但无法可靠地确定停止生命支持治疗后 1 或 2 小时内死亡的潜在心脏死亡后供体。因此,应在每一个潜在的供体中启动捐献程序。